103 results
Page 3 of 6
8-K
3jrfduih8hx43xs
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
8-K
EX-99.1
j6kijhleh shzp
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
8-K
EX-99.2
o9gykbh479k jw4y
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
S-8
EX-10.1
wrsub9h3upspy99mq
15 Oct 21
Registration of securities for employees
5:01pm
SC TO-I
EX-99
159mt6u 91a0km
26 Aug 21
Issuer tender offer statement
4:55pm
8-K
EX-99.1
1zrice
9 Aug 21
TherapeuticsMD Announces Appointment of Hugh O’Dowd as President
4:35pm
8-K
86ngkpydj674 q7k
9 Aug 21
TherapeuticsMD Announces Appointment of Hugh O’Dowd as President
4:35pm
S-3ASR
afic9mu okq7cua
4 Mar 21
Automatic shelf registration
12:00am
8-K
EX-99.2
jpa6bb0
2 Mar 21
TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results
7:00am
424B2
nfxxs2mnawv4ivmr16
16 Feb 21
Prospectus for primary offering
6:17am
424B5
jbtp7sllhjsnnuaf
10 Feb 21
Prospectus supplement for primary offering
5:11pm
424B5
g9s4elwgza0bxei62sim
27 Nov 20
Prospectus supplement for primary offering
4:46pm
424B2
votz oooja87
12 Nov 20
Prospectus for primary offering
5:18pm
424B5
ost13 208
9 Nov 20
Prospectus supplement for primary offering
5:27pm